Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy

International Journal of Gynecological Cancer

Volumn 20, Issue 4, 2010, Pages 564-569

  Kumar, Vinita Jaggi ^a   Nin, Chia Yin ^a   Kuei, Lim Yong ^a   Tan, Khoo H S ^b   Yeo, Richard ^b   Lam, Philip Yam Kwai ^a  

^a Department of Gynaecological Oncology   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Brachytherapy; Endometrioid; Recurrence free survival; Stage I; Uterus

Indexed keywords

IRIDIUM 192;

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; DISTANT METASTASIS; DOSE RESPONSE; DRUG MEGADOSE; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SINGAPORE; SURVIVAL RATE; TUMOR VOLUME; UTERUS CARCINOMA; VAGINA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 77952253225     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d7ce94     Document Type: Article

References (19)

1. Trope GC, Alektiar KM, Sabbatini PJ, et al. Corpus: epithelial tumors. In: Hoskins WJ, ed. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:823-872.
2. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A gynecologic Oncology Group study. Cancer. 1987;60:2035-2041.
3. Gal D, Recio OF, Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer. 1992;69:200-202.
4. Aoki Y, Watanabe M, Amikura T, et al. Adjuvant chemotherapy as treatment of high risk stage I and II endometrial cancer. Gynecol Oncol. 2004;94:333-339.
5. Morrow CP, Bundy BN, Kurman R, et al. Relationship between surgical-pathological risk factors and outcome in clinical stages 1 and 2 carcinoma of the endometrium (a GOG study). Gynecol Oncol. 1991;40:55-65.
6. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
7. Wolfson AH, Sightler SE, Markoe AM, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol. 1992;45:142-146.
8. Creutzberg CL. Lymphadenectomy in apparent early stage endometrial carcinoma: do numbers count? J Clin Oncol. 2005;23:3653-3655.
9. Rittenberg PV, Lotocki RJ, Heywood MS, et al. High risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. Gynecol Oncol. 2003;89:288-294.
10. Corn BW, Lanciano RM, D'Agostino R Jr, et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol. 1997;66:411-416.
11. Chadha M, Nanavati PJ, Liu P, et al. Patterns of failure in endometrial carcinoma stage 1B grade3 and 1C patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol. 1999;75:103-107.
12. Ng TY, Perrin LC, Nicklin JL, et al. Local recurrence in high-risk node-negative stage 1 endometrial carcinoma treated with postoperative vaginal vault brachytherapy. 2000;79:490-494.
13. Obermair A, Cheuk R, Pak SC, et al. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma. Gynecol Oncol. 2008;110:280-285.
14. Zaino RJ, Kurman RJ, Diana KL, et al. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer. 1996;77:1120.
15. Creutzberg CL, van Putten W L J, Warlam-Rodenhuis CC, et al. Outcome of high risk stage 1C, G3, compared with stage 1 endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol. 2004;22:1234-1241.
16. Creutzberg CL, Van Putten WL, Koper P, et al. Survival after relapse in patients with endometrial cancer: results from a randomised trial. Gynecol Oncol. 2003;89:201-209.
17. Wylie J, Irwin C, Pintilie M, et al. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol. 2000;77:66-72.
18. Shah C, Johnson B, Everette E, et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol. 2005;99:564-570.
19. Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomised PORTEC-2 trial [abstract]. J Clin Oncol. 2008;26: Abstract LBA 5503.